Intravenous Benlysta is the first biologic treatment to be approved for children with lupus in Europe
GlaxoSmithKline plc today announced that the...
Read MoreGlaxoSmithKline plc today announced that the...
Read MoreDrug major Dr Reddy's on...
Read MoreFujitsu Limited today announced that...
Read MoreBiopharmaceutical company, MediciNova, Inc has received a...
Read MoreThe Union Minister for Science...
Read MoreAn apex body for Ayurvedic...
Read MoreTensions between the United States...
Read MoreRecognizing its pioneering efforts of...
Read MoreDenmark-based Bavarian Nordic has signed...
Read MoreAxsome Therapeutics, Inc. (NASDAQ: AXSM),...
Read More